Agenus | AGEN - Ebit





Ebit Changement Date
AbbVie USD 5.81B 4.36B 2025-12
Agenus USD 14.4M 19.26M 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Celldex Therapeutics USD -87.15M 13.54M 2025-12
CSL USD 2.64B 116M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Incyte USD 383.88M 47.44M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
J&J USD 5.11B 2.3B 2025-12
Jiangsu Hengrui CNY 1.41B 1.4B 2025-09
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
MacroGenics USD -12.1M 32.26M 2025-12
Merck EUR 474M 738M 2025-12
Merck USD 6.24B 1.32B 2025-12
Northwest Biotherapeutics USD -13.82M 248K 2023-09
Novartis USD 4.06B 530M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 24.63M 1.52M 2025-12